Special Issue "Recent Advances in Personalized Cervical Cancer Screening"
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (20 June 2023) | Viewed by 2977
Special Issue Editors
Interests: HPV; cervical cancer; cervical screening; HPV genotyping; HPV vaccination; cancer
Interests: human papillomavirus (HPV); epidemiologic studies; cervical cancer; cancer epidemiology; epidemiological modeling; epidemiologic methods; cervical cancer screening
Special Issue Information
Dear Colleagues,
A large majority of cervical cancer (more than 95%) is due to the human papillomavirus (HPV). The risk of disease progression and cancer is highly dependent on HPV genotype, and the use of HPV genotyping is increasingly finding its way into cervical screening programs.
The detailed genotyping information allows for an improved risk stratification, where women are approached and treated according to the risk they run. A great challenge remains, however, regarding how risk-based screening should be implemented in organized screening programs. This implementation should be tailored to the setting where HPV vaccinated cohorts are entering the screening programs. In addition, there are several recent developments related to cervical screening, as self-sampling, urine sampling and the use of methylation markers, that promise important parts of the screening programs.
This Special Issue aims to provide researchers with an opportunity to publish both original research and review articles related to methods for improved and more personalized cervical cancer and pre-cancer predictions based on the increasing amount of relevant information, including HPV genotyping, HPV vaccination information, and data from more recent methodologies for cervical cancer screening.
Dr. Ståle Nygård
Dr. Mari Nygård
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV
- cervical cancer
- cervical screening
- HPV genotyping
- HPV vaccination
- personalized medicine
